<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJS</journal-id>
<journal-id journal-id-type="hwp">spijs</journal-id>
<journal-id journal-id-type="nlm-ta">Int J Surg Pathol</journal-id>
<journal-title>International Journal of Surgical Pathology</journal-title>
<issn pub-type="ppub">1066-8969</issn>
<issn pub-type="epub">1940-2465</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1066896912454567</article-id>
<article-id pub-id-type="publisher-id">10.1177_1066896912454567</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>SALL4 and SF-1 Are Sensitive and Specific Markers for Distinguishing Granulosa Cell Tumors From Yolk Sac Tumors</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Bai</surname><given-names>Shuting</given-names></name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-1066896912454567">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Wei</surname><given-names>Shi</given-names></name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff2-1066896912454567">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Ziober</surname><given-names>Amy</given-names></name>
<degrees>JD</degrees>
<xref ref-type="aff" rid="aff1-1066896912454567">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Yao</surname><given-names>Yuan</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1066896912454567">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Bing</surname><given-names>Zhanyong</given-names></name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-1066896912454567">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-1066896912454567"><label>1</label>Hospital of the University of Pennsylvania, Philadelphia, PA, USA</aff>
<aff id="aff2-1066896912454567"><label>2</label>University of Alabama, Birmingham, AL, USA</aff>
<author-notes>
<corresp id="corresp1-1066896912454567">Zhanyong Bing, Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, 6 Founders, 3400 Spruce Street, Philadelphia, PA 19104, USA Email: <email>bingz@uphs.upenn.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>4</month>
<year>2013</year>
</pub-date>
<volume>21</volume>
<issue>2</issue>
<fpage>121</fpage>
<lpage>125</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Granulosa cell tumors are classified as juvenile and adult types. They may be misinterpreted as a yolk sac tumor when they exhibit a “reticular” growth pattern and contain prominent mitotic activity. In this study, the authors performed immunohistochemical stains for SALL4 and steroidogenic factor-1 (SF-1) on 27 cases of yolk sac tumors and 24 granulosa cell tumors. Nuclear stains for both antibodies were considered as positive and the intensity of staining was graded as negative, weak, moderate, and strong. All the yolk sac tumors were positive for SALL4 (100%) with moderate to strong grade staining and negative for SF-1 (100%). In contrast, all the granulosa cell tumors were positive for SF-1 (85% moderate to strong grade staining and 15% weak staining) and negative for SALL4 (100%). The difference was significant (<italic>P</italic> &lt; .01, Student’s <italic>t</italic> test). This result indicates that these 2 markers could be used to distinguish these 2 tumors in a difficult situation.</p>
</abstract>
<kwd-group>
<kwd>granulosa cell tumor</kwd>
<kwd>yolk sac tumor</kwd>
<kwd>SALL4</kwd>
<kwd>SF-1</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1066896912454567" sec-type="intro">
<title>Introduction</title>
<p>Granulosa cell tumors are the most common type of ovarian sex-cord stromal tumor, which have malignant potential and comprise 2% to 5% of all ovarian tumors.<sup><xref ref-type="bibr" rid="bibr1-1066896912454567">1</xref>,<xref ref-type="bibr" rid="bibr2-1066896912454567">2</xref></sup> There are 2 subtypes—adult and juvenile. The adult subtype, which occurs most commonly in middle-aged and older women (median age 50-54 years), comprises 95% of these tumors. On the other hand, the juvenile type typically develops before puberty and is more common among children and young women and accounts for 5%.<sup><xref ref-type="bibr" rid="bibr3-1066896912454567">3</xref></sup> This subtype tends to have a higher proliferative rate than the adult type and has a lower risk for late recurrences. Granulosa cell tumor in the testicle is rare and there are only 29 cases of adult type reported in the English literature.<sup><xref ref-type="bibr" rid="bibr4-1066896912454567">4</xref>,<xref ref-type="bibr" rid="bibr5-1066896912454567">5</xref></sup></p>
<p>Yolk sac tumor (also called endodermal sinus tumor) is a malignant germ cell tumor that usually arises in the gonads.<sup><xref ref-type="bibr" rid="bibr6-1066896912454567">6</xref></sup> This is the third most common form of ovarian malignant germ cell tumor (~1% of cases) and is a common component of mixed malignant germ cell tumors of the testis.<sup><xref ref-type="bibr" rid="bibr7-1066896912454567">7</xref></sup> In the ovary, most of them occur as pure forms, whereas pure yolk sac tumors of the testis are rare in adults but is the most common testicular germ cell tumor in children. The pure testicular yolk sac tumor in children peaks at 1.5 years of age and represents about 70% of pediatric testicular germ cell tumors.<sup><xref ref-type="bibr" rid="bibr8-1066896912454567">8</xref></sup> There are numerous growth patterns of yolk sac tumors, such as tubular, cystic, papillary, solid, glandular, reticular, and hepatoid patterns.<sup><xref ref-type="bibr" rid="bibr9-1066896912454567">9</xref><xref ref-type="bibr" rid="bibr10-1066896912454567"/><xref ref-type="bibr" rid="bibr11-1066896912454567"/><xref ref-type="bibr" rid="bibr12-1066896912454567"/><xref ref-type="bibr" rid="bibr13-1066896912454567"/>-<xref ref-type="bibr" rid="bibr14-1066896912454567">14</xref></sup></p>
<p>Granulosa cell tumor, especially juvenile type, may be misinterpreted as a yolk sac tumor when it exhibits a “reticular” growth pattern and contains prominent mitotic activity.<sup><xref ref-type="bibr" rid="bibr1-1066896912454567">1</xref></sup> Even though immunohistochemical (IHC) expression of α-fetoprotein and inhibin-α can be used to distinguish these 2 tumors, the reliability of antibodies targeting α-fetoproteins in tissues is often questioned. IHC for inhibin-α appears to be the most sensitive and specific for granulosa cell tumors.<sup><xref ref-type="bibr" rid="bibr15-1066896912454567">15</xref>,<xref ref-type="bibr" rid="bibr16-1066896912454567">16</xref></sup> Malignant germ cell tumors, including yolk sac tumors, can also be positive for this marker.<sup><xref ref-type="bibr" rid="bibr17-1066896912454567">17</xref></sup> Since the approaches to treating these 2 tumors are drastically different, alternative markers need to be explored.</p>
<p>Recently, 2 novel markers were identified for aiding in the diagnosis of germ cell tumors and sex-cord stromal tumors, SALL4 and steroidogenic factor-1 (SF-1). SALL4, a zinc finger transcriptional factor, was noted as a specific marker for subtyping of germ cell tumors, including seminoma, embryonal carcinoma, and yolk sac tumor.<sup><xref ref-type="bibr" rid="bibr18-1066896912454567">18</xref>,<xref ref-type="bibr" rid="bibr19-1066896912454567">19</xref></sup> SF-1 is a nuclear receptor that plays an important role in regulating many aspects of adrenal and reproductive development and function.<sup><xref ref-type="bibr" rid="bibr20-1066896912454567">20</xref><xref ref-type="bibr" rid="bibr21-1066896912454567"/><xref ref-type="bibr" rid="bibr22-1066896912454567"/>-<xref ref-type="bibr" rid="bibr23-1066896912454567">23</xref></sup> SF-1 has been shown to be expressed in various sex-cord stromal tumors, including Sertoli cell tumor, Sertoli–Leydig cell tumor, steroid cell tumor and fibroma/fibrothecoma, and juvenile granulosa cell tumor.<sup><xref ref-type="bibr" rid="bibr24-1066896912454567">24</xref><xref ref-type="bibr" rid="bibr25-1066896912454567"/>-<xref ref-type="bibr" rid="bibr26-1066896912454567">26</xref></sup> Whether SALL4 and SF-1 can be used as a concise panel of markers to distinguish yolk sac tumor from granulosa cell tumor has not been elucidated. In this study, we evaluated IHC stains for SALL4 and SF-1 in the differential diagnosis of yolk sac tumors and granulosa cell tumors.</p>
</sec>
<sec id="section2-1066896912454567" sec-type="materials|methods">
<title>Materials and Methods</title>
<p>The Surgical Pathology databases of the Hospital of the University of Pennsylvania and University of Alabama at Birmingham Hospital were searched to identify granulosa cell tumors and yolk sac tumors. In all, 24 cases of granulosa cell tumors (3 juvenile type and 22 adult type) and 27 cases of yolk sac tumors were retrieved. The study was approved by the institutional review board,</p>
<p>All cases were immunohistochemically stained with SF-1 and SALL4 antibodies.</p>
<p>For SF-1 (clone N1665, R&amp;D Systems, Inc, Minneapolis, MN), antigen retrieval was achieved by incubating slides for 20 minutes at 100°C in citrate buffer. This was followed by cooling to room temperature, blocking endogenous peroxidase for 10 minutes, and incubating with Protein Block (Envision + System, Dako, Glostrup, Denmark) for 30 minutes at room temperature. After primary antibody incubation for 45 minutes at room temperature, slides were washed and incubated with horseradish peroxidase polymer for 30 minutes, washed, visualized with 3,3′-diaminobenzidine (DAB), and counterstained with hematoxylin.</p>
<p>For SALL4 (Santa Cruz Biotechnology, Inc, Santa Cruz, CA), the immunostaining was performed using a mouse monoclonal antibody against SALL4 of human origin (clone EE-30) on the fully automated Leica Microsystems’ Bond-Max Immunohistochemistry system (Leica Microsystems, Bannockburn, IL). After heating tissue sections in a 70°C oven for 1 hour, they were transferred to the Bond-Max Autostainer for deparaffinization, clearing, epitope retrieval, and immunohistochemical staining. Heat-induced epitope retrieval was accomplished using citrate buffer, pH 6.0 for 20 minutes at 100°C. Sections were incubated with the SALL4 antibody at 1:100 for 15 minutes at room temperature followed by detection of the antigen with a biotin-free polymeric horseradish peroxidase–linker antibody conjugate system (Refine Polymer, Leica Microsystems) for 8 minutes at room temperature. Blocking of endogenous peroxidase was performed by incubating tissue sections in 3.0% H<sub>2</sub>O<sub>2</sub> for 7 minutes. Staining was visualized with 3,3′-diaminobenzidine substrate chromogen for 10 minutes, rinsed in di-H<sub>2</sub>O, and counterstained with hematoxylin. Slides were manually dehydrated through a series of graded alcohol, cleared in a series of xylene, and mounted.</p>
<p>Nuclear stains for both antibodies were evaluated and the intensity of staining was graded as negative, weak, moderate, and strong. Statistical significance was derived using Student’s <italic>t</italic> test.</p>
</sec>
<sec id="section3-1066896912454567" sec-type="results">
<title>Results</title>
<p>All the cases were reviewed and pathological diagnoses were confirmed and clinical histories are summarized in <xref ref-type="table" rid="table1-1066896912454567">Table 1</xref>. Twenty-three out of 24 granulosa cell tumors (96%) were from female patients’ ovaries with the age ranging from 16 to 85 years (average 52 years), one testicular granulosa cell tumor (4%) was from a 28-year-old male patient. Three ovarian cases were juvenile type whereas the rest were adult type (<xref ref-type="table" rid="table2-1066896912454567">Table 2</xref>). Most of the yolk sac tumors (<xref ref-type="fig" rid="fig1-1066896912454567">Figure 1C</xref>) were from testicles (18 cases, 67%), 1 case from ovary (4%), and remaining cases were from anterior mediastinal areas or other sites with metastatic tumors (8 cases, 29%) of male patients.</p>
<table-wrap id="table1-1066896912454567" position="float">
<label>Table 1.</label>
<caption>
<p>Clinical Histories of Granulosa Cell Tumors and Yolk Sac Tumors</p>
</caption>
<graphic alternate-form-of="table1-1066896912454567" xlink:href="10.1177_1066896912454567-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Group</th>
<th align="center">Granulosa Cell Tumor</th>
<th align="center">Yolk Sac Tumor</th>
</tr>
</thead>
<tbody>
<tr>
<td>Male</td>
<td>1</td>
<td>26</td>
</tr>
<tr>
<td>Female</td>
<td>23 (3 juvenile type)</td>
<td>1</td>
</tr>
<tr>
<td>Age range in years (mean)</td>
<td>16-71 (50)</td>
<td>24-68 (35)</td>
</tr>
<tr>
<td>Ovary</td>
<td>24</td>
<td>1</td>
</tr>
<tr>
<td>Testis</td>
<td>1</td>
<td>18</td>
</tr>
<tr>
<td>Other sites</td>
<td>0</td>
<td>8</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="table2-1066896912454567" position="float">
<label>Table 2.</label>
<caption>
<p>Immunohistochemical Stains for Granulosa Cell Tumors and Yolk Sac Tumors</p>
</caption>
<graphic alternate-form-of="table2-1066896912454567" xlink:href="10.1177_1066896912454567-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Tumor Type</th>
<th align="center">SF-1; n (%)</th>
<th align="center">SALL4; n (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Granulosa cell tumor</td>
<td>24 (100)</td>
<td>0 (0)</td>
</tr>
<tr>
<td> Juvenile type</td>
<td>3 (100)</td>
<td>0 (0)</td>
</tr>
<tr>
<td> Adult type</td>
<td>21 (100)</td>
<td>0 (0)</td>
</tr>
<tr>
<td>Yolk sac tumor</td>
<td>0 (0)</td>
<td>27 (100)</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="fig1-1066896912454567" position="float">
<label>Figure 1.</label>
<caption>
<p>SF-1 and SALL4 stains in the granulosa cell tumors (A-C) and yolk sac tumors (D-F), magnification 200×. A and D, hematoxylin and eosin stains; B and E, SF-1 stains; C and F, SALL4 stains</p>
</caption>
<graphic xlink:href="10.1177_1066896912454567-fig1.tif"/></fig>
<p>All the granulosa cell tumors were positive for SF-1 (85% with moderate to strong nuclear staining and 15% with weak nuclear staining; <xref ref-type="fig" rid="fig1-1066896912454567">Figure 1B</xref>) and negative for SALL4 (100%; <xref ref-type="fig" rid="fig1-1066896912454567">Figure 1C</xref>). In contrast, all the yolk sac tumors (<xref ref-type="fig" rid="fig1-1066896912454567">Figure 1D</xref>) were positive for SALL4 (100%) with moderate to strong staining (<xref ref-type="fig" rid="fig1-1066896912454567">Figure 1F</xref>) and negative for SF-1 (100%; <xref ref-type="fig" rid="fig1-1066896912454567">Figure 1E</xref>). The difference was significant (<italic>P</italic> &lt; .01; Student’s <italic>t</italic> test).</p>
</sec>
<sec id="section4-1066896912454567" sec-type="discussion">
<title>Discussion</title>
<p>Granulosa cell tumors, especially juvenile type, can exhibit “reticular” growth pattern, which may be misinterpreted as yolk sac tumors. As the approaches to treat these 2 tumors are drastically different, correct diagnosis is imperative. Though morphology alone may resolve the diagnoses for most cases, immunohistochemical staining may be required for differential diagnosis in a difficult situation. In this study, we evaluated expression patterns of 2 newly described markers, SALL4 and SF-1, in granulosa cell tumors and yolk sac tumors.</p>
<p>SALL4 is a zinc finger transcriptional factor that shares homology to the Drosophila spalt (sal) gene and acts upstream of OCT 3/4, one of the markers for primitive germ cell tumors. Recently, SALL4 was shown to be strongly expressed in yolk sac tumors in addition to other germ cell tumors, such as gonadoblastoma, dysgerminoma, and embryonal carcinoma.<sup><xref ref-type="bibr" rid="bibr18-1066896912454567">18</xref>,<xref ref-type="bibr" rid="bibr19-1066896912454567">19</xref></sup> It was also reported as being negative in granulosa cell tumors in one study (10 cases of adult type and 8 cases of juvenile type).<sup><xref ref-type="bibr" rid="bibr18-1066896912454567">18</xref></sup></p>
<p>SF-1, also known as Ad4-binding protein (Ad4BP), originally described in 1992, is an orphan member of the nuclear hormone receptor superfamily and is considered to play an important role in the differentiation of steroidogenic tissues. SF-1 is a nuclear transcription factor that regulates genes that are involved in steroidogenesis, development of gonads and adrenal glands, sexual differentiation, reproduction, and metabolism. In a prior study, all primary ovarian epithelial tumors and metastatic carcinomas involving the ovaries (stomach and breast) were negative for SF-1 staining.<sup><xref ref-type="bibr" rid="bibr27-1066896912454567">27</xref></sup> In this study, all granulosa cell tumors were positive for this marker, which was consistent with previous report.<sup><xref ref-type="bibr" rid="bibr24-1066896912454567">24</xref></sup> Recently, one study reported that SF-1 could be expressed in some yolk sac tumors.<sup><xref ref-type="bibr" rid="bibr27-1066896912454567">27</xref></sup> It showed that yolk sac tumors heterogeneously expressed GATA-4, GATA-6, and their target gene SF-1, whereas they remained negative for the other GATA target genes, such as anti-Mullerian hormone and inhibin-α.</p>
<p>To further clarify the staining patterns of SALL4 and SF-1 in granulosa cell tumors and yolk sac tumors and to evaluate whether the duo could be a good concise discriminatory panel in a difficult situation for the differential diagnosis of yolk sac tumorss and granulosa cell tumors, we performed IHC stains for SALL4 and SF-1 on these 2 types of tumors. From our results, all the yolk sac tumors were positive for SALL4 and negative for SF-1, whereas all the granulosa cell tumors were positive for SF-1 and negative for SALL4.</p>
<p>The staining pattern of SALL4 was consistent with other prior studies, which showed that SALL4 was positive in some types of germ cell tumors, including seminoma/ dysgerminoma, embryonal carcinoma, and yolk sac tumors, whereas negative for granulosa cell tumors. However, interestingly, our result indicated SF-1 was totally negative in yolk sac tumor, but positive in both adult and juvenile types of granulosa cell tumors, which was different from the results of a prior study, which showed SF-1 to be heterogeneously expressed in yolk sac tumor cells.<sup><xref ref-type="bibr" rid="bibr27-1066896912454567">27</xref></sup> The cause for such discrepancy is unknown; however, it may be because of the usage of different antibodies from different manufactories. More experiments need to be performed to compare the expression of SF-1 in yolk sac tumors by using these 2 SF-1 antibodies in one institution.</p>
<p>In summary, we compared the expression patterns of SALL4 and SF-1 in these 2 types of tumors. Our results indicated that SALL4 and SF-1 can be used as a pair of markers in distinguishing granulosa cell tumors from yolk sac tumors, particularly when juvenile type granulosa cell tumors exhibit “reticular” growth pattern, which might be misinterpreted as a yolk sac tumor.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<label>Declaration of Conflicting Interests</label>
<p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>The author(s) received no financial support for the research, authorship, and/or publication of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1066896912454567">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Young</surname><given-names>RH.</given-names></name>
</person-group> <article-title>Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems</article-title>. <source>Mod Pathol</source>. <year>2005</year>;<volume>18</volume>(<supplement>suppl 2</supplement>):<fpage>S81</fpage>-<lpage>S98</lpage>.</citation>
</ref>
<ref id="bibr2-1066896912454567">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Koukourakis</surname><given-names>GV</given-names></name>
<name><surname>Kouloulias</surname><given-names>VE</given-names></name>
<name><surname>Koukourakis</surname><given-names>MJ</given-names></name><etal/>
</person-group>. <article-title>Granulosa cell tumor of the ovary: tumor review</article-title>. <source>Integr Cancer Ther</source>. <year>2008</year>;<volume>7</volume>:<fpage>204</fpage>-<lpage>215</lpage>.</citation>
</ref>
<ref id="bibr3-1066896912454567">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lack</surname><given-names>EE</given-names></name>
<name><surname>Perez-Atayde</surname><given-names>AR</given-names></name>
<name><surname>Murthy</surname><given-names>AS</given-names></name>
<name><surname>Goldstein</surname><given-names>DP</given-names></name>
<name><surname>Crigler</surname><given-names>JF</given-names><suffix>Jr</suffix></name>
<name><surname>Vawter</surname><given-names>GF.</given-names></name>
</person-group> <article-title>Granulosa theca cell tumors in premenarchal girls: a clinical and pathologic study of ten cases</article-title>. <source>Cancer</source>. <year>1981</year>;<volume>48</volume>:<fpage>1846</fpage>-<lpage>1854</lpage>.</citation>
</ref>
<ref id="bibr4-1066896912454567">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hanson</surname><given-names>JA</given-names></name>
<name><surname>Ambaye</surname><given-names>AB.</given-names></name>
</person-group> <article-title>Adult testicular granulosa cell tumor: a review of the literature for clinicopathologic predictors of malignancy</article-title>. <source>Arch Pathol Lab Med</source>. <year>2011</year>;<volume>135</volume>:<fpage>143</fpage>-<lpage>146</lpage>.</citation>
</ref>
<ref id="bibr5-1066896912454567">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Song</surname><given-names>Z</given-names></name>
<name><surname>Vaughn</surname><given-names>DJ</given-names></name>
<name><surname>Bing</surname><given-names>Z.</given-names></name>
</person-group> <article-title>Adult type granulosa cell tumor in adult testis: report of a case and review of the literature</article-title>. <source>Rare Tumors</source>. <year>2011</year>;<volume>3</volume>:<fpage>117</fpage>-<lpage>119</lpage>.</citation>
</ref>
<ref id="bibr6-1066896912454567">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ulbright</surname><given-names>TM.</given-names></name>
</person-group> <article-title>Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues</article-title>. <source>Mod Pathol</source>. <year>2005</year>;<volume>18</volume>(<supplement>suppl 2</supplement>):<fpage>S61</fpage>-<lpage>S79</lpage>.</citation>
</ref>
<ref id="bibr7-1066896912454567">
<label>7.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Scully</surname><given-names>RE</given-names></name>
<name><surname>Young</surname><given-names>RH</given-names></name>
<name><surname>Clement</surname><given-names>PR.</given-names></name>
</person-group> <source>Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tube, and Broad Ligament</source>. <publisher-loc>Atlas of Tumor Pathology No. 23. Washington, DC</publisher-loc>: <publisher-name>Armed Forces Institute of Pathology</publisher-name>; <year>1998</year>.</citation>
</ref>
<ref id="bibr8-1066896912454567">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Grady</surname><given-names>RW</given-names></name>
<name><surname>Ross</surname><given-names>JH</given-names></name>
<name><surname>Kay</surname><given-names>R.</given-names></name>
</person-group> <article-title>Patterns of metastatic spread in prepubertal yolk sac tumor of the testis</article-title>. <source>J Urol</source>. <year>1995</year>;<volume>153</volume>: <fpage>1259</fpage>-<lpage>1261</lpage>.</citation>
</ref>
<ref id="bibr9-1066896912454567">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Teilum</surname><given-names>G.</given-names></name>
</person-group> <article-title>Classification of endodermal sinus tumor (mesoblastoma vitellinum) and so-called “embryonal carcinoma” of the ovary</article-title>. <source>Acta Pathol Microbiol Scand</source>. <year>1965</year>;<volume>64</volume>:<fpage>407</fpage>-<lpage>429</lpage>.</citation>
</ref>
<ref id="bibr10-1066896912454567">
<label>10.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Teilum</surname><given-names>G.</given-names></name>
</person-group> <source>Special Tumors of Ovary and Testis and Related Extragonadal Lesions</source>. <publisher-loc>Philadelphia, PA</publisher-loc>: <publisher-name>J. B. Lippincott</publisher-name>; <year>1976</year>.</citation>
</ref>
<ref id="bibr11-1066896912454567">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Teilum</surname><given-names>G.</given-names></name>
</person-group> <article-title>“Mesonephroma ovarii” (Schiller)—an extra-embryonic mesoblastoma of germ cell origin in the ovary and the testis</article-title>. <source>Acta Pathol Microbiol Scand</source>. <year>1950</year>;<volume>27</volume>:<fpage>249</fpage>-<lpage>261</lpage>.</citation>
</ref>
<ref id="bibr12-1066896912454567">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Teilum</surname><given-names>G.</given-names></name>
</person-group> <article-title>Endodermal sinus tumors of the ovary and testis: comparative morphogenesis of the so-called mesonephroma ovarii (Schiller) and extraembryonic (yolk sac-allantoic) structures of the rat’s placenta</article-title>. <source>Cancer</source>. <year>1959</year>;<volume>12</volume>:<fpage>1092</fpage>-<lpage>1105</lpage>.</citation>
</ref>
<ref id="bibr13-1066896912454567">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kao</surname><given-names>CS</given-names></name>
<name><surname>Idrees</surname><given-names>MT</given-names></name>
<name><surname>Young</surname><given-names>RH</given-names></name>
<name><surname>Ulbright</surname><given-names>TM.</given-names></name>
</person-group> <article-title>Solid pattern yolk sac tumor: a morphologic and immunohistochemical study of 52 cases</article-title>. <source>Am J Surg Pathol</source>. <year>2012</year>;<volume>36</volume>:<fpage>360</fpage>-<lpage>367</lpage>. doi:<pub-id pub-id-type="doi">10.1097/PAS.0b013e31823c510b</pub-id>.</citation>
</ref>
<ref id="bibr14-1066896912454567">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ulbright</surname><given-names>TM</given-names></name>
<name><surname>Roth</surname><given-names>LM</given-names></name>
<name><surname>Brodhecker</surname><given-names>CA.</given-names></name>
</person-group> <article-title>Yolk sac differentiation in germ cell tumors. A morphologic study of 50 cases with emphasis on hepatic, enteric, and parietal yolk sac features</article-title>. <source>Am J Surg Pathol</source>. <year>1986</year>;<volume>10</volume>:<fpage>151</fpage>-<lpage>164</lpage>.</citation>
</ref>
<ref id="bibr15-1066896912454567">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McCluggage</surname><given-names>WG.</given-names></name>
</person-group> <article-title>Recent advances in immunohistochemistry in the diagnosis of ovarian neoplasms</article-title>. <source>J Clin Pathol</source>. <year>2000</year>;<volume>53</volume>:<fpage>327</fpage>-<lpage>334</lpage>.</citation>
</ref>
<ref id="bibr16-1066896912454567">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Movahedi-Lankarani</surname><given-names>S</given-names></name>
<name><surname>Kurman</surname><given-names>RJ.</given-names></name>
</person-group> <article-title>Calretinin, a more sensitive but less specific marker than alpha-inhibin for ovarian sex cord-stromal neoplasms: an immunohistochemical study of 215 cases</article-title>. <source>Am J Surg Pathol</source>. <year>2002</year>;<volume>26</volume>:<fpage>1477</fpage>-<lpage>1483</lpage>.</citation>
</ref>
<ref id="bibr17-1066896912454567">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cobellis</surname><given-names>L</given-names></name>
<name><surname>Cataldi</surname><given-names>P</given-names></name>
<name><surname>Reis</surname><given-names>FM</given-names></name><etal/>
</person-group>. <article-title>Gonadal malignant germ cell tumors express immunoreactive inhibin/activin subunits</article-title>. <source>Eur J Endocrinol</source>. <year>2001</year>;<volume>145</volume>:<fpage>779</fpage>-<lpage>784</lpage>.</citation>
</ref>
<ref id="bibr18-1066896912454567">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cao</surname><given-names>D</given-names></name>
<name><surname>Guo</surname><given-names>S</given-names></name>
<name><surname>Allan</surname><given-names>RW</given-names></name>
<name><surname>Molberg</surname><given-names>KH</given-names></name>
<name><surname>Peng</surname><given-names>Y.</given-names></name>
</person-group> <article-title>SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma</article-title>. <source>Am J Surg Pathol</source>. <year>2009</year>;<volume>33</volume>:<fpage>894</fpage>-<lpage>904</lpage>.</citation>
</ref>
<ref id="bibr19-1066896912454567">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cao</surname><given-names>D</given-names></name>
<name><surname>Humphrey</surname><given-names>PA</given-names></name>
<name><surname>Allan</surname><given-names>RW.</given-names></name>
</person-group> <article-title>SALL4 is a novel sensitive and specific marker for metastatic germ cell tumors, with particular utility in detection of metastatic yolk sac tumors</article-title>. <source>Cancer</source>. <year>2009</year>;<volume>115</volume>:<fpage>2640</fpage>-<lpage>2651</lpage>.</citation>
</ref>
<ref id="bibr20-1066896912454567">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Parker</surname><given-names>KL</given-names></name>
<name><surname>Schimmer</surname><given-names>BP.</given-names></name>
</person-group> <article-title>Steroidogenic factor 1: a key determinant of endocrine development and function</article-title>. <source>Endocr Rev</source>. <year>1997</year>;<volume>18</volume>:<fpage>361</fpage>-<lpage>377</lpage>.</citation>
</ref>
<ref id="bibr21-1066896912454567">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sadovsky</surname><given-names>Y</given-names></name>
<name><surname>Dorn</surname><given-names>C.</given-names></name>
</person-group> <article-title>Function of steroidogenic factor 1 during development and differentiation of the reproductive system</article-title>. <source>Rev Reprod</source>. <year>2000</year>;<volume>5</volume>:<fpage>136</fpage>-<lpage>142</lpage>.</citation>
</ref>
<ref id="bibr22-1066896912454567">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Urs</surname><given-names>AN</given-names></name>
<name><surname>Dammer</surname><given-names>E</given-names></name>
<name><surname>Kelly</surname><given-names>S</given-names></name>
<name><surname>Wang</surname><given-names>E</given-names></name>
<name><surname>Merrill</surname><given-names>AH</given-names><suffix>Jr</suffix></name>
<name><surname>Sewer</surname><given-names>MB.</given-names></name>
</person-group> <article-title>Steroidogenic factor-1 is a sphingolipid binding protein</article-title>. <source>Mol Cell Endocrinol</source>. <year>2007</year>;<fpage>265</fpage>-<lpage>266</lpage>:174-178.</citation>
</ref>
<ref id="bibr23-1066896912454567">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schimmer</surname><given-names>BP</given-names></name>
<name><surname>White</surname><given-names>PC.</given-names></name>
</person-group> <article-title>Minireview: Steroidogenic factor 1: its roles in differentiation, development, and disease</article-title>. <source>Mol Endocrinol</source>. <year>2010</year>;<volume>24</volume>:<fpage>1322</fpage>-<lpage>1337</lpage>.</citation>
</ref>
<ref id="bibr24-1066896912454567">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhao</surname><given-names>C</given-names></name>
<name><surname>Vinh</surname><given-names>TN</given-names></name>
<name><surname>McManus</surname><given-names>K</given-names></name>
<name><surname>Dabbs</surname><given-names>D</given-names></name>
<name><surname>Barner</surname><given-names>R</given-names></name>
<name><surname>Vang</surname><given-names>R.</given-names></name>
</person-group> <article-title>Identification of the most sensitive and robust imunohistochemical markers in different categories of ovarian sex cord-stromal tumors</article-title>. <source>Am J Surg Pathol</source>. <year>2009</year>;<volume>33</volume>:<fpage>354</fpage>-<lpage>366</lpage>.</citation>
</ref>
<ref id="bibr25-1066896912454567">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Saasano</surname><given-names>H</given-names></name>
<name><surname>Imaizumi</surname><given-names>H</given-names></name>
<name><surname>Nagura</surname><given-names>H.</given-names></name>
</person-group> <article-title>Juvenile granulosa cell tumor discovered during pregnancy: case report with immunohistochemical study of steroidogenesis</article-title>. <source>Pathol Int</source>. <year>1997</year>;<volume>47</volume>:<fpage>325</fpage>-<lpage>328</lpage>.</citation>
</ref>
<ref id="bibr26-1066896912454567">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sasano</surname><given-names>H</given-names></name>
<name><surname>Kaga</surname><given-names>K</given-names></name>
<name><surname>Sato</surname><given-names>S</given-names></name>
<name><surname>Yajima</surname><given-names>A</given-names></name>
<name><surname>Nagura</surname><given-names>H.</given-names></name>
</person-group> <article-title>Adrenal 4-binding protein in common epithelial and metastatic tumors of the ovary</article-title>. <source>Hum Pathol</source>. <year>1996</year>;<volume>27</volume>:<fpage>595</fpage>-<lpage>598</lpage>.</citation>
</ref>
<ref id="bibr27-1066896912454567">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Salonen</surname><given-names>J</given-names></name>
<name><surname>Rajpert-De Meyts</surname><given-names>E</given-names></name>
<name><surname>Mannisto</surname><given-names>S</given-names></name><etal/>
</person-group>. <article-title>Differential developmental expression of transcription factors GATA-4 and GATA-6, their cofactor FOG-2 and downstream target genes in testicular carcinoma in situ and germ cell tumors</article-title>. <source>Eur J Endocrinol</source>. <year>2010</year>;<volume>162</volume>:<fpage>625</fpage>-<lpage>631</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>